TAM
DNTH icon

Tyers Asset Management’s Dianthus Therapeutics DNTH Stock Holding History

Tyers Asset Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$12K Hold
76
– – ﹤0.01% 979
2019
Q2 		$18K Hold
76
– – ﹤0.01% 965
2019
Q1 		$20K Hold
76
– – ﹤0.01% 955
2018
Q4 		$7K Sell
76
-62
-45% -$8.45K ﹤0.01% 947
2018
Q3 		$27K Hold
138
– – ﹤0.01% 952
2018
Q2 		$30K Buy
+138
New +$31.1K ﹤0.01% 936

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Tyers Asset Management's DNTH Position: Q3 2019 in Review

Tyers Asset Management held its Dianthus Therapeutics (DNTH) position steady in Q3 2019 at 76 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #979.

Tyers Asset Management first reported a position in DNTH in Q2 2018 and has held it in 6 quarters since. The position peaked at $30K in Q2 2018. 72 funds tracked by Wall St. Rank hold DNTH as of Q3 2019.

  • Tyers Asset Management held 76 shares of Dianthus Therapeutics worth $12K as of Q3 2019.
  • Tyers Asset Management left its Dianthus Therapeutics share count unchanged in Q3 2019.
  • Dianthus Therapeutics made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #979 holding.
  • Tyers Asset Management first reported a position in Dianthus Therapeutics in Q2 2018 and has held it in 6 quarters since.
  • Tyers Asset Management's Dianthus Therapeutics position peaked at $30K in Q2 2018.
  • 72 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.